Jackson Immuno Research Inc.
specializing in secondary antibodies and conjugates
Mar 23 22

Celebrating 40 years!

Courtney Scardellette

This March marks the 40th anniversary of Jackson ImmunoResearch Laboratories, Inc., founded by William J. Stegeman Ph.D. The company started as a small biotech manufacturing immunological products for the research community and is now a global leader of secondary antibody manufacturing.

While working at Cappel Laboratories in the late 1970s, Bill Stegeman and current President Ralph Hood, had the realization that there were very few options for secondary antibodies on the market. They took a risk, started their own lab and committed to developing best in class reagents with support from the other principle owners, Leonard Guinta DO and Lawrence O’Donnell.  Over the years, the Jackson ImmunoResearch team pioneered a number of advances in secondary antibody manufacture. This included the development of Affinity-Purification, universally known today as “AffiniPure,” and the Lyophilization process, which set the industry standard for product stability.

The quality and consistency of Jackson ImmunoResearch’s products quickly made them the “go-to detection reagent” for scientists around the world, with over 100,000 citations on Google Scholars to date. To better support their customers and extend the company’s footprint beyond West Grove, PA, global distribution partners were established over the years. In 2004, partner company Jackson ImmunoResearch Europe was founded and continues to be led by Managing Director, Sue Hallett.

Fast forward to 2022 and the mission at Jackson ImmunoResearch remains the same: Scientists creating tools for scientists. Enhancing scientific discovery by providing the highest quality immunological tools to the life science and diagnostic communities is at the core of what we do. It’s rewarding to see our products play a role in so many important fields including neuroscience, oncology, food safety, and diagnostics. The spirited culture that began in the early years is still alive, boosted with continued investment in talent and technology to drive innovation and ensure we are prepared to meet our customers’ needs as they grow and evolve.

On behalf of Jackson ImmunoResearch, we want to thank all of our customers, big and small, and our employees, past and present, for the last forty years. It’s an especially exciting time to work in science and we look forward to what’s next!

Comments are closed.

  • Recent Posts

    • The Evolution of DNA-PAINT

      Download PDF First reported in 2010, DNA points accumulation for imaging in nanoscale topography (DNA-PAINT) is a super-resolution microscopy (SRM) technique that can be performed with existing antibody reagents and …Read More »
    • Why use a particular Antibody format?

      Download PDF Here, we discuss the differences between the different antibody formats available, including H+L, F(ab′)2, Fab, and VHH fragment antibodies. We will address how they can offer solutions to …Read More »
    • See you at AACR 2025!

      Download PDF Will we see you at AACR 2025 in Chicago this April? If so, stop by booth #710 and complete our short survey for a chance to win an …Read More »
    • Imaging with Jackson ImmunoResearch Secondary Antibodies

      Download PDF Imaging using immunostaining is a commonly used technique that can elucidate many details about how a process functions in situ. It is applied in many fields, including cancer …Read More »
    • The Origins and Longevity of IgE Responses

      Download PDF A recent review, authored by researchers at Monash University, Australia, looks at potential sources of IgE and suggests how these could serve as therapeutic targets for allergic diseases. …Read More »